Strategies in the Design of Endosomolytic Agents for Facilitating Endosomal Escape in Nanoparticles

If endosomolytic agents are designed based on rational strategies—including pH-sensitive charge transition, membrane destabilization, proton-sponge effects, and photochemical internalization—and are appropriately incorporated into lipid- or polymer-based nanoparticles, then endosomal escape can be significantly enhanced, leading to improved gene expression and drug delivery efficacy while minimizing cytotoxicity.

• Secondary Aims:
• To explore and categorize the diverse design strategies for endosomolytic agents (anionic, cationic, pH-sensitive peptides, polymers, lipids, toxins).
• To discuss modification approaches for equipping lipid and polymer nanoparticles with endosomolytic agents.
• To highlight recent advancements, future directions, and challenges in the development of endosomolytic agent-modified NPs for nanomedicine applications.

Platform Type: Lipid-based NPs; Examples Discussed: Cationic liposomes, fusogenic lipid DOPE, pH-sensitive lipids (citraconyl-DOPE), charge-reversal lipids, PEG-lipid conjugates (pH-sensitive linkers: ortho ester, hydrazone, vinyl ether), cholesterol-GALA peptide-modified liposomes

Platform Type: Polymer-based NPs; Examples Discussed: Polyethylenimine (PEI), branched PEI (brPEI), dendrimers (PAMAM), chitosan, polylysine (PLL), histidine-modified polylysine, pH-sensitive smart polymers (PEAA, PPAA, PDSA), Eudragit E/L/S, HPMC-P/AS

Platform Type: Peptide-based systems; Examples Discussed: Cell-penetrating peptides (TAT, penetratin, oligoarginine, transportan, Pep-1, TP10), fusogenic peptides (HA2, GALA, KALA, INF7, JTS1, EALA, H5WYG, ppTG1, ppTG20, LAH4, SAP)

Platform Type: Toxin-based systems; Examples Discussed: Diphtheria toxin T domain, Listeriolysin O (LLO), Shiga toxin, Cholera toxin, Exotoxin A, Ricin, Saporin

Platform Type: Viral vectors (natural); Examples Discussed: Adenovirus, Rhinovirus, Influenza virus, Sendai virus, Rotavirus

Platform Type: Chemical agents; Examples Discussed: Chloroquine (proton sponge), photosensitizers (DPc, AlPcS2a, TPPS4, TPPS2a) for photochemical internalization

Payloads discussed: Plasmid DNA (pDNA), siRNA, oligonucleotides, splice-correcting PNAs, drugs, contrast agents, peptides/proteins.

Targeting ligands: Transferrin, Her-2 targeting, folate targeting.

• Literature synthesis of endosomal escape mechanisms across viral, bacterial toxin, plant toxin, peptide, polymer, and lipid-based systems.
• Comparative analysis between natural viral escape mechanisms and synthetic biomimetic strategies.
• Categorization of endosomolytic agents by charge (anionic vs. cationic), origin (viral, bacterial, plant, synthetic), and mechanism (membrane fusion, pore formation, proton sponge, photochemical internalization).
• Tabulation of selected endosomolytic agents with their sequences and mechanisms (Table 1 and Table 2).
• Figure-based mechanistic models illustrating endocytosis pathways, endosomal escape mechanisms, proton sponge hypothesis, and photochemical internalization.

No primary experimental data is presented; all data are derived from previously published studies.

• Endocytic pathway classification: Phagocytosis vs. pinocytosis (macropinocytosis, clathrin-mediated, caveolin-mediated, clathrin/caveolin-independent endocytosis).
• Design strategies for pH-sensitive anionic peptides: Insertion/substitution of acidic residues (Asp, Glu) into native sequences (e.g., INF7 from HA2, GALA, JTS1, EALA).
• Design strategies for cationic peptides: Substitution of acidic residues with basic ones (Lys, Arg, His) (e.g., KALA from GALA, H5WYG, histidine-rich peptides).
• Polymer design: Branched co-polymers of histidine and lysine; dendrimer synthesis via divergent/convergent methods, Lego chemistry, Click chemistry.
• Nanoparticle modification strategies: Covalent conjugation (cysteine-maleimide, amide bonds), non-covalent electrostatic interactions, PEGylation with pH-sensitive linkers, disulfide bond incorporation.
• Mechanistic analysis: Membrane destabilization (carpet model, barrel-stave model, toroidal pore), proton-sponge hypothesis, photochemical internalization (ROS generation), membrane fusion (flip-flop mechanism).
• Cytotoxicity assessment: Hemolytic activity at pH 7.4 vs. pH 5.0, mammalian cell toxicity, immunogenicity.

1. Endosomal entrapment is a major bottleneck: Most NPs enter cells via endocytic pathways and are degraded in lysosomes; only a small fraction escape to the cytosol.

2. Charge transition is a key design principle: pH-sensitive anionic peptides (e.g., GALA, INF7, JTS1) and cationic peptides (e.g., KALA, H5WYG, LAH4) exploit the pH drop from ~7.4 (physiological) to ~5.0–6.0 (endosomal) to trigger membrane destabilization. Histidine (pKa ~6.0) is particularly useful for selective activation at endosomal pH.

3. Proton-sponge mechanism is debated: PEI and PAMAM dendrimers are thought to buffer endosomal pH, causing osmotic swelling and rupture, but recent evidence suggests buffering alone is insufficient; membrane disruption by pore formation may be the dominant mechanism.

4. Photochemical internalization (PCI) is a promising light-triggered approach: Photosensitizers (e.g., AlPcS2a, TPPS2a) generate reactive oxygen species upon light activation, rupturing endosomal membranes and releasing cargo into the cytosol.

5. Viral mechanisms inform synthetic design: Enveloped viruses use membrane fusion (e.g., influenza HA2); non-enveloped viruses use pore formation or membrane destabilization (e.g., adenovirus protein VI). These mechanisms inspire peptide-based endosomolytic agents.

6. Toxicity remains a major limitation: Many potent endosomolytic agents (e.g., melittin, bacterial toxins, PEI) are highly cytotoxic. Strategies to mitigate toxicity include: - Reversible masking with dimethyl maleic anhydride (DMMAn) that cleaves at acidic pH (e.g., modified melittin). - Substitution of negatively charged residues with basic residues to reduce cytotoxicity at physiological pH (e.g., LL-37, melittin, bombolitin V analogs). - PEGylation and acid-labile linkers.

7. Design strategies for NP modification: - Lipid NPs: DOPE phase transition (lamellar → inverted hexagonal) at low pH; pH-sensitive PEG-lipid conjugates (ortho ester, hydrazone, vinyl ether linkers); charge-reversal lipids; cholesterol-GALA peptide incorporation. - Polymer NPs: Histidine/lysine co-polymers; branched PEI; dendrimers; pH-sensitive smart polymers (PEAA, PPAA, PDSA); surface modification with arginine, SWNTs, gelatin-PEI.

8. Early endosome targeting is preferable: Escaping from early endosomes (neutral to slightly acidic pH) is better than late endosomes/lysosomes (highly acidic, high hydrolytic enzyme content).

• Endosomal escape is a critical and underexplored barrier in non-viral gene and drug delivery.
• Peptide-based endosomolytic agents are particularly promising due to their biodegradability, biocompatibility, low immunogenicity, and ability to be genetically encoded.
• Rational design strategies—including pH-sensitive charge transition, membrane destabilization, proton-sponge effects, and photochemical internalization—can be used to create novel endosomolytic agents.
• Viral-derived peptides (e.g., HA2, INF7) and antimicrobial peptides (e.g., melittin, LL-37 analogs) provide templates for designing safer, more effective endosomolytic agents.
• Future challenges include: reducing cytotoxicity at physiological pH, understanding structure-function relationships, elucidating the complex endosomal environment, improving NP conjugation chemistry, and scaling up production for clinical translation.
• The ideal vector should combine efficient cellular uptake, endosomal escape, low toxicity, biodegradability, biocompatibility, and low immunogenicity.

The authors position this review as a comprehensive resource for researchers designing next-generation nanocarriers equipped with endosomolytic agents.

• No primary experimental data: As a narrative review, it synthesizes existing literature without generating new data.
• Lack of systematic review methodology: No explicit search strategy, inclusion/exclusion criteria, or meta-analysis are reported.
• Mechanistic understanding remains incomplete: The authors acknowledge that the interaction mechanism of NPs with endosomal membranes is "poorly understood," and the proton-sponge hypothesis is contested.
• Limited clinical translation discussion: While future directions are mentioned, there is limited discussion of clinical trial data or regulatory challenges.
• Toxicity data are heterogeneous: Cytotoxicity findings are drawn from diverse studies with varying cell lines, assays, and conditions, making direct comparisons difficult.
• No quantitative comparison: The review does not provide quantitative benchmarks (e.g., % endosomal escape, IC50 values) across different endosomolytic agents.
• Publication bias: Positive results are likely overrepresented in the reviewed literature.

Limitations of the field highlighted by the authors:

• High toxicity, low stability, and high immunogenicity of many endosomolytic agents.
• Difficult synthesis and conjugation of endosomolytic agents to nanocarriers.
• Poor understanding of structure-function relationships.
• Endosomal release from early endosomes is preferable but challenging to achieve.
• NP-based formulations suffer from particle agglomeration, difficult physical handling, low drug loading/release capacity, and polydispersity control issues.

Section: Citation; Key Points: Ahmad et al., Biochimie, 2019, DOI: 10.1016/j.biochi.2019.02.012

Section: Purpose; Key Points: Address endosomal escape bottleneck in NP-based gene/drug delivery

Section: Hypothesis; Key Points: Rational design of endosomolytic agents enhances endosomal escape and therapeutic efficacy

Section: Aims; Key Points: Review escape mechanisms; explore design strategies; discuss NP modification; highlight future directions

Section: Delivery Systems; Key Points: Lipid NPs, polymer NPs, peptides, toxins, viral vectors, chemical agents

Section: Approach; Key Points: Narrative literature review with comparative mechanistic analysis

Section: Key Methods; Key Points: Endocytic pathway classification, peptide design strategies, polymer chemistry, NP modification, mechanistic models

Section: Key Results; Key Points: Charge transition, proton-sponge debate, PCI, viral mimicry, toxicity mitigation, early endosome targeting

Section: Significance; Key Points: Peptide-based agents promising; rational design strategies can yield safer, more effective vectors

Section: Limitations; Key Points: No primary data, incomplete mechanistic understanding, toxicity, no quantitative benchmarks